Veterinary Medicines

INGELVAC MYCOFLEX SUSPENSION FOR INJECTION FOR PIGS

Authorised
  • Mycoplasma hyopneumoniae, strain J, Inactivated
Download as PDF

Product identification

Medicine name:
INGELVAC MYCOFLEX SUSPENSION FOR INJECTION FOR PIGS
Ingelvac MycoFLEX Injektionsvätska, suspension
Active substance:
  • Mycoplasma hyopneumoniae, strain J, Inactivated
Target species:
  • Pig (for fattening)
  • Pig (for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, strain J, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (for fattening)
      • All relevant tissues
        0
        day
    • Pig (for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • Cardboard box with 1 high density polyethylene bottle of 10 ml (10 doses)
  • Cardboard box with 12 high density polyethylene TwistPak bottles of 250 ml (250 doses)
  • Cardboard box with12 high density polyethylene TwistPak bottles of 100 ml (100 doses)
  • Cardboard box with 12 high density polyethylene TwistPak bottles 50 ml (50 doses)
  • Cardboard box with 12 high density polyethylene TwistPak bottles of 10 ml (10 doses)
  • Cardboard box with 1 density polyethylene TwistPak bottle of 250 ml (250 doses in 250 ml) vaccine
  • Cardboard box with 1 density polyethylene TwistPak bottle of 100 ml (100 doses)
  • Cardboard box with 1 density polyethylene TwistPak bottle of 50 ml (50 doses)
  • Cardboard box with 1 density polyethylene TwistPak bottle of 10 ml (10 doses)
  • Cardboard box with 12 high density polyethylene bottles of 250 ml (250 doses)
  • Cardboard box with 12 high density polyethylene bottles of 100 ml (100 doses)
  • Cardboard box with 12 high density polyethylene bottles of 50 ml (50 doses)
  • Cardboard box with 12 high density polyethylene bottles of 10 ml (10 doses)
  • Cardboard box with 1 high density polyethylene bottle of 250 ml (250 doses)
  • Cardboard box with 1 high density polyethylene bottle of 100 ml (100 doses)
  • Cardboard box with 1 high density polyethylene bottle of 50 ml (50 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 41800
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0203/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/09/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/09/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/09/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."